Search

everythinglearnresearchcommunity

for

Search:↓

The letter is skeptical about the effectiveness of anti-androgen therapy for COVID-19 and calls for strong evidence from clinical trials.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

The new gel for hair loss is safe, effective, and reduces side effects.

Combining low-dose dutasteride with finasteride improved a man's hair loss.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

5-alpha reductase inhibitors slightly reduce urinary symptoms and may lower surgery and acute retention risks in men.

Estradiol and castration reduced prostate cancer development in rats when applied at early stages, but were ineffective after cancer was established.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Finasteride, a drug that prevents testosterone conversion, can effectively reduce blood loss in prostate surgery, especially for patients with a prostatic volume over 30 cc, and decrease post-surgery complications.

Mesotherapy with dutasteride effectively treats hair loss with manageable side effects.

Long-term, low-dose finasteride may reduce the risk of benign prostatic hyperplasia and prostate cancer.

Low-dose dutasteride effectively and safely promotes hair growth in men with androgenetic alopecia.

Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.

The method accurately measures cyproterone acetate in plasma, showing no significant difference between two formulations.

Finasteride may help treat Neutrophil Actin Dysfunction by reducing LSP1 gene activity.

GI197111X is best dissolved in Capmul MCM for trials.

New oral testosterone formulations show potential for safer, effective hormone replacement in men with low testosterone.

Finasteride and levofloxacin effectively reduce chronic bacterial prostatitis severity.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Finasteride and dutasteride's effects are mainly due to target binding saturation and slow enzyme turnover.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

Dutasteride effectively and safely treats male hair loss for over a year.

Torilin from Torilis japonica can inhibit testosterone 5α-reductase but is less effective than finasteride.

Finasteride and dutasteride might lower melanoma risk.